2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
This is a phase 3 clinical investigation. Patients who meet the eligibility criteria and
provide signed informed consent will be randomized to receive one of two levels of Ferrlecit
or oral iron in a 1:1:1 ratio.